Scientific Background and Reference Sources
ACMG. (2021). ACMG Technical Standards for Clinical Genetics Laboratories (2021 Revision): Clinical Molecular Genetics (Section G). https://www.acmg.net/PDFLibrary/ACMG%20Technical%20Lab%20Standards%20Section%20G.pdf
ACOG. (2016). Committee Opinion No.682: Microarrays and Next-Generation Sequencing Technology: The Use of Advanced Genetic Diagnostic Tools in Obstetrics and Gynecology. Obstet Gynecol, 128(6), e262-e268. https://doi.org/10.1097/aog.0000000000001817
Affymetrix. (2013). CytoScan® Cytogenetics Suite. https://assets.thermofisher.com/TFS-Assets/LSG/brochures/CL00731-9-Brochure-CytoScan-Cytogenetics-Suite_final.pdf
AMP. (2023). "Molecular in My Pocket™" Reference Card Series. Association for Molecular Pathology. https://www.amp.org/education/amp-review-resources/molecular-in-my-pocket-guides/
Armour, C. M., Dougan, S. D., Brock, J. A., Chari, R., Chodirker, B. N., DeBie, I., Evans, J. A., Gibson, W. T., Kolomietz, E., Nelson, T. N., Tihy, F., Thomas, M. A., & Stavropoulos, D. J. (2018). Practice guideline: joint CCMG-SOGC recommendations for the use of chromosomal microarray analysis for prenatal diagnosis and assessment of fetal loss in Canada. J Med Genet, 55(4), 215-221. https://doi.org/10.1136/jmedgenet-2017-105013
ASRM. (2012). Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertility and Sterility, 98(5), 1103-1111. https://doi.org/10.1016/j.fertnstert.2012.06.048
ASRM. (2020). Clinical management of mosaic results from preimplantation genetic testing for aneuploidy (PGT-A) of blastocysts: a committee opinion. Fertil Steril, 114(2), 246-254. https://doi.org/10.1016/j.fertnstert.2020.05.014
Bajaj Lall, M., Agarwal, S., Paliwal, P., Saviour, P., Joshi, A., Joshi, A., Mahajan, S., Bijarnia-Mahay, S., Dua Puri, R., & Verma, I. C. (2021). Prenatal Diagnosis by Chromosome Microarray Analysis, An Indian Experience. J Obstet Gynaecol India, 71(2), 156-167. https://doi.org/10.1007/s13224-020-01413-6
Borrell, A., Grande, M., Pauta, M., Rodriguez-Revenga, L., & Figueras, F. (2017). Chromosomal Microarray Analysis in Fetuses with Growth Restriction and Normal Karyotype: A Systematic Review and Meta-Analysis. Fetal Diagn Ther. https://doi.org/10.1159/000479506
Brady, P. D., Chiaie, B. D., Christenhusz, G., Dierickx, K., Bogaert, K. V. D., Menten, B., Janssens, S., Defoort, P., Roets, E., Sleurs, E., Keymolen, K., Catte, L. D., Deprest, J., Ravel, T. d., Esch, H. V., Fryns, J. P., Devriendt, K., & Vermeesch, J. R. (2013). A prospective study of the clinical utility of prenatal chromosomal microarray analysis in fetuses with ultrasound abnormalities and an exploration of a framework for reporting unclassified variants and risk factors. Genetics in Medicine, 16, 469-476. https://doi.org/doi:10.1038/gim.2013.168
CentoGene. (2024). Chromosomal Microarray Analysis with CentoArrayCyto®. https://www.centogene.com/diagnostics/chromosomal-microarray-testing.html
Chau Matthew, H. W., Yunli Lai, Yanyan Zhang, Fuben Xu, Yanqing Tang, Yanfang Wang, Zihan Chen, Tak Yeung Leung, Jacqueline Pui Wah Chung, Yvonne K Kwok, Shuk Ching Chong, Kwong Wai Choy, Yuanfang Zhu, Likuan Xiong, Weihong Wei, Zirui Dong. (2020). Low-pass genome sequencing: a validated method in clinical cytogenetics. Human Genetics. https://doi.org/10.1007/s00439-020-02185-9
Chau, M. H. K., Wang, H., Lai, Y., Zhang, Y., Xu, F., Tang, Y., Wang, Y., Chen, Z., Leung, T. Y., Chung, J. P. W., Kwok, Y. K., Chong, S. C., Choy, K. W., Zhu, Y., Xiong, L., Wei, W., & Dong, Z. (2020). Low-pass genome sequencing: a validated method in clinical cytogenetics. Hum Genet, 139(11), 1403-1415. https://doi.org/10.1007/s00439-020-02185-9
Cherry, A. M., Akkari, Y. M., Barr, K. M., Kearney, H. M., Rose, N. C., South, S. T., Tepperberg, J. H., & Meck, J. M. (2017). Diagnostic cytogenetic testing following positive noninvasive prenatal screening results: a clinical laboratory practice resource of the American College of Medical Genetics and Genomics (ACMG). Genet Med, 19(8), 845-850. https://doi.org/10.1038/gim.2017.91
Cohen, P., Rogol, A. D., Deal, C. L., Saenger, P., Reiter, E. O., Ross, J. L., Chernausek, S. D., Savage, M. O., & Wit, J. M. (2008). Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop. J Clin Endocrinol Metab, 93(11), 4210-4217. https://doi.org/10.1210/jc.2008-0509
Dubbs, H. (2022). NATIONAL COORDINATING CENTER for EPILEPSY Epilepsy Overview. https://www.aap.org/en/patient-care/epilepsy/diagnosing-pediatric-epilepsy/genetic-testing-for-epilepsy/
FDA. (2014). Affymetrix® CytoScan® Dx Assay. https://www.accessdata.fda.gov/cdrh_docs/reviews/K130313.pdf
FDA. (2017). GenetiSure Dx Postnatal Assay. https://www.accessdata.fda.gov/cdrh_docs/pdf16/K163367.pdf
Fox, N. S., Monteagudo, A., Kuller, J. A., Craigo, S., & Norton, M. E. (2018). Mild fetal ventriculomegaly: diagnosis, evaluation, and management. Am J Obstet Gynecol, 219(1), B2-b9. https://doi.org/10.1016/j.ajog.2018.04.039
Gencove. (2023). Low-pass sequencing and imputation for evaluating genetic variation. https://gencove.com/blog/low-pass-whole-genome-sequencing
GeneDx. (2024). Chromosomal Microarray (GenomeDx®). https://providers.genedx.com/tests/detail/chromosomal-microarray-718
Gregg, A. R., Skotko, B. G., Benkendorf, J. L., Monaghan, K. G., Bajaj, K., Best, R. G., Klugman, S., & Watson, M. S. (2016). Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics. Genet Med, 18(10), 1056-1065. https://doi.org/10.1038/gim.2016.97
Hay, S. B., Sahoo, T., Travis, M. K., Hovanes, K., Dzidic, N., Doherty, C., & Strecker, M. N. (2018). ACOG and SMFM guidelines for prenatal diagnosis: Is karyotyping really sufficient? Prenat Diagn. https://doi.org/10.1002/pd.5212
Hyman, S. L., Levy, S. E., & Myers, S. M. (2020). Identification, Evaluation, and Management of Children With Autism Spectrum Disorder. Pediatrics, 145(1). https://doi.org/10.1542/peds.2019-3447
Illumina. (2024). Coverage depth recommendations. https://www.illumina.com/science/technology/next-generation-sequencing/plan-experiments/coverage.html
Invitae. (2024). Invitae Pregnancy Loss Chromosomal Microarray Analysis for FFPE. https://www.invitae.com/en/physician/tests/81120/
ISPD. (2018). Joint Position Statement from the International Society for Prenatal Diagnosis (ISPD), the Society for Maternal Fetal Medicine (SMFM), and the Perinatal Quality Foundation (PQF) on the use of genome-wide sequencing for fetal diagnosis. Prenat Diagn, 38(1), 6-9. https://doi.org/10.1002/pd.5195
LabCorp. (2023). SNP Microarray−Pediatric (Reveal®). https://www.labcorp.com/tests/510002/snp-microarray-pediatric-reveal
Li, Y., Anderson, L. A., Ginns, E. I., & Devlin, J. J. (2018). Cost Effectiveness of Karyotyping, Chromosomal Microarray Analysis, and Targeted Next-Generation Sequencing of Patients with Unexplained Global Developmental Delay or Intellectual Disability. Mol Diagn Ther, 22(1), 129-138. https://doi.org/10.1007/s40291-017-0309-5
Lineagen. (2024). FirstStepDx PLUS®. https://lineagen.com/parents/our-testing-services/firststepdx-plus/
Lipkin, P. H., & Macias, M. M. (2020). Promoting Optimal Development: Identifying Infants and Young Children With Developmental Disorders Through Developmental Surveillance and Screening. Pediatrics, 145(1). https://doi.org/10.1542/peds.2019-3449
Mandy, G. T. (2024, August 18). Infants with fetal (intrauterine) growth restriction. https://www.uptodate.com/contents/infants-with-fetal-intrauterine-growth-restriction
Manning, M., & Hudgins, L. (2010). Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities. Genet Med, 12(11), 742-745. https://doi.org/10.1097/GIM.0b013e3181f8baad
Mardy, A. H., Rangwala, N., Hernandez-Cruz, Y., Gosnell, K. A., Gonzalez, J. M., Norton, M. E., & Sparks, T. N. (2020). Utility of chromosomal microarray for diagnosis in cases of nonimmune hydrops fetalis. Prenat Diagn. https://doi.org/10.1002/pd.5617
Martins, J. G., Biggio, J. R., & Abuhamad, A. (2020). Society for Maternal-Fetal Medicine Consult Series #52: Diagnosis and management of fetal growth restriction: (Replaces Clinical Guideline Number 3, April 2012). Am J Obstet Gynecol, 223(4), B2-b17. https://doi.org/10.1016/j.ajog.2020.05.010
Mazzonetto, P. C., Villela, D., da Costa, S. S., Krepischi, A. C. V., Milanezi, F., Migliavacca, M. P., Pierry, P. M., Bonaldi, A., Almeida, L. G. D., De Souza, C. A., Kroll, J. E., Paula, M. G., Guarischi-Sousa, R., Scapulatempo-Neto, C., & Rosenberg, C. (2024). Low-pass whole genome sequencing is a reliable and cost-effective approach for copy number variant analysis in the clinical setting. Ann Hum Genet, 88(2), 113-125. https://doi.org/10.1111/ahg.12532
Mefford, H. C. (2015). Clinical Genetic Testing in Epilepsy. Epilepsy Curr, 15(4), 197-201. https://doi.org/10.5698/1535-7511-15.4.197
Miller, D. (2022, July 15). Prenatal diagnosis of chromosomal imbalance: Chromosomal microarray. https://www.uptodate.com/contents/use-of-chromosomal-microarray-in-obstetrics
Miller, D. T., Adam, M. P., Aradhya, S., Biesecker, L. G., Brothman, A. R., Carter, N. P., Church, D. M., Crolla, J. A., Eichler, E. E., Epstein, C. J., Faucett, W. A., Feuk, L., Friedman, J. M., Hamosh, A., Jackson, L., Kaminsky, E. B., Kok, K., Krantz, I. D., Kuhn, R. M., . . . Ledbetter, D. H. (2010). Consensus Statement: Chromosomal Microarray Is a First-Tier Clinical Diagnostic Test for Individuals with Developmental Disabilities or Congenital Anomalies. In Am J Hum Genet (Vol. 86, pp. 749-764). https://doi.org/10.1016/j.ajhg.2010.04.006
Moeschler, J. B., & Shevell, M. (2014). Comprehensive evaluation of the child with intellectual disability or global developmental delays. Pediatrics, 134(3), e903-918. https://doi.org/10.1542/peds.2014-1839
Monaghan, K. G., Leach, N. T., Pekarek, D., Prasad, P., Rose, N. C., on behalf of the, A. P. P., & Guidelines, C. (2020). The use of fetal exome sequencing in prenatal diagnosis: a points to consider document of the American College of Medical Genetics and Genomics (ACMG). Genetics in Medicine, 22(4), 675-680. https://doi.org/10.1038/s41436-019-0731-7
Monier, I., Receveur, A., Houfflin-Debarge, V., Goua, V., Castaigne, V., Jouannic, J. M., Mousty, E., Saliou, A. H., Bouchghoul, H., Rousseau, T., Valat, A. S., Groussolles, M., Fuchs, F., Benoist, G., Degre, S., Massardier, J., Tsatsaris, V., Kleinfinger, P., Zeitlin, J., & Benachi, A. (2021). Should prenatal chromosomal microarray analysis be offered for isolated fetal growth restriction? A French multicenter study. Am J Obstet Gynecol, 225(6), 676.e671-676.e615. https://doi.org/10.1016/j.ajog.2021.05.035
Nagan, N., Faulkner, N. E., Curtis, C., & Schrijver, I. (2011). Laboratory guidelines for detection, interpretation, and reporting of maternal cell contamination in prenatal analyses a report of the association for molecular pathology. J Mol Diagn, 13(1), 7-11. https://doi.org/10.1016/j.jmoldx.2010.11.013
National FragileX Foundation. (2024). Fragile X Syndrome Testing & Diagnosis. https://www.fragilex.org/understanding-fragile-x/fragile-x-101/testing-diagnosis/
Norton, M. E., Chauhan, S. P., & Dashe, J. S. (2015). Society for maternal-fetal medicine (SMFM) clinical guideline #7: nonimmune hydrops fetalis. Am J Obstet Gynecol, 212(2), 127-139. https://doi.org/10.1016/j.ajog.2014.12.018
Pasternak, Y., Daykan, Y., Tenne, T., Reinstein, E., Miller, N., Shechter-Maor, G., Maya, I., Biron-Shental, T., & Sukenik Halevy, R. (2020). The yield of chromosomal microarray analysis among pregnancies terminated due to fetal malformations. J Matern Fetal Neonatal Med, 1-5. https://doi.org/10.1080/14767058.2020.1716722
Quest. (2024). Why ClariSure® CMA. https://www.questdiagnostics.com/home/physicians/testing-services/by-test-name/clarisure/why-clarisure/
Robson, S. C., Chitty, L. S., Morris, S., Verhoef, T., Ambler, G., Wellesley, D. G., Graham, R., Leader, C., Fisher, J., & Crolla, J. A. (2017). Efficacy and Mechanism Evaluation. Evaluation of Array Comparative genomic Hybridisation in prenatal diagnosis of fetal anomalies: a multicentre cohort study with cost analysis and assessment of patient, health professional and commissioner preferences for array comparative genomic hybridisation. https://doi.org/10.3310/eme04010
Rodriguez-Revenga, L., Madrigal, I., Borrell, A., Martinez, J. M., Sabria, J., Martin, L., Jimenez, W., Mira, A., Badenas, C., & Milà, M. (2020). Chromosome microarray analysis should be offered to all invasive prenatal diagnostic testing following a normal rapid aneuploidy test result. Clinical Genetics, 98(4), 379-383. https://doi.org/10.1111/cge.13810
Satya-Murti, S., Cohen, B.H., and Michelson, D. (2015). Chromosomal microarray analysis for intellectual disabilities. American Academy of Neurology. https://www.aan.com/siteassets/home-page/tools-and-resources/practicing-neurologist--administrators/billing-and-coding/model-coverage-policies/15microarrayanalysismodel_tr.pdf
Seaver, L. H., & Irons, M. (2009). ACMG practice guideline: genetic evaluation of short stature. Genet Med, 11(6), 465-470. https://doi.org/10.1097/GIM.0b013e3181a7e8f8
Shen, Y., Dies, K. A., Holm, I. A., Bridgemohan, C., Sobeih, M. M., Caronna, E. B., Miller, K. J., Frazier, J. A., Silverstein, I., Picker, J., Weissman, L., Raffalli, P., Jeste, S., Demmer, L. A., Peters, H. K., Brewster, S. J., Kowalczyk, S. J., Rosen-Sheidley, B., McGowan, C., . . . Miller, D. T. (2010). Clinical genetic testing for patients with autism spectrum disorders. Pediatrics, 125(4), e727-735. https://doi.org/10.1542/peds.2009-1684
Waggoner, D., Wain, K. E., Dubuc, A. M., Conlin, L., Hickey, S. E., Lamb, A. N., Martin, C. L., Morton, C. C., Rasmussen, K., Schuette, J. L., Schwartz, S., & Miller, D. T. (2018). Yield of additional genetic testing after chromosomal microarray for diagnosis of neurodevelopmental disability and congenital anomalies: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG). Genet Med, 20(10), 1105-1113. https://doi.org/10.1038/s41436-018-0040-6
Wang, H., Dong, Z., Zhang, R., Chau, M. H. K., Yang, Z., Tsang, K. Y. C., Wong, H. K., Gui, B., Meng, Z., Xiao, K., Zhu, X., Wang, Y., Chen, S., Leung, T. Y., Cheung, S. W., Kwok, Y. K., Morton, C. C., Zhu, Y., & Choy, K. W. (2020). Low-pass genome sequencing versus chromosomal microarray analysis: implementation in prenatal diagnosis. Genet Med, 22(3), 500-510. https://doi.org/10.1038/s41436-019-0634-7
Zhang, Y., Zhong, M., & Zheng, D. (2021). Chromosomal mosaicism detected by karyotyping and chromosomal microarray analysis in prenatal diagnosis. J Cell Mol Med, 25(1), 358-366. https://doi.org/10.1111/jcmm.16080Specialty Matched Consultant Advisory Panel 3/2020
Medical Director review 7/2022
Medical Director Review 7/2023
Medical Director Review 7/2024